45 SMEs from 19 countries have been selected in the latest round of the Horizon 2020 SME Instrument (Phase 2).

The 30 chosen projects will each receive between €0.5m and €2.5m to bring their product from the pilot phase to the market. Health projects will receive up to €5m. The participating SMEs will also benefit from 12 days of business coaching.

Among the successful projects are Colodetect, which aims to develop a novel blood-based diagnostic test for colorectal cancer; HTPush, which is intended to set up a universal and compatible system for plumbing and heating; and AquaSHIELD, which hopes to protect people against contaminated water via the creation of a water quality firewall.

A total of 1,090 project proposals were submitted under Phase 2 of the SME Instrument by 25 November, the fourth and final cut-off date for 2015.

UK SMEs proved the most successful with seven beneficiaries and €10m in funding; Italy followed with six SMEs and a €4.3m total investment.

Altogether, 356 SMEs have been selected under Phase 2 of the SME Instrument since the programme’s launch on 1 January 2014.

The post 45 SMEs secure SME Instrument funding appeared first on Horizon 2020 Projects.